APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biomarkers

In biological system, it means to calculate the whole number by marking part of individuals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In biological system, it means to calculate the whole number by marking part of individuals.

Selected research

Market Outlook & Growth Opportunities

Global Biomarkers Market Outlook and Growth Opportunities 2026

Report ID 173893650431 December 2025197 pages

Choose your research edition.

Industry ResearchBiomarkers Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomarkers Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomarkers Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomarkers Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

In biological system, it means to calculate the whole number by marking part of individuals.

North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.

This report provides an overview of the global Biomarkers market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Biomarkers and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomarkers revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomarkers market.

Biomarkers Segment by Company

Thermo Fisher Scientific

Merck

Bio-Rad Laboratories

QIAGEN

Roche

Danaher Corporation

Siemens Healthcare

Abbott

Agilent Technologies

Biomarkers Segment by Type

Sepsis Biomarkers

Antibiotic Resistance Biomarkers

Traumatic Brain Injury (TBI) Testing Biomarkers

Stroke Testing Biomarkers

Antibiotic Stewardship Biomarkers

Other

Biomarkers Segment by Application

Diagnostics

Drug Discovery

Personalized Medicine

Other

Biomarkers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomarkers status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomarkers key companies, revenue, market share, and recent developments.

3. To split the Biomarkers breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomarkers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomarkers significant trends, drivers, influence factors in global and regions.

6. To analyze Biomarkers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomarkers industry.

Chapter 3: Detailed analysis of Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomarkers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomarkers Industry Trends Table 2. Biomarkers Industry Drivers Table 3. Biomarkers Industry Opportunities and Challenges Table 4. Biomarkers Industry Restraints Table 5. Global Biomarkers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomarkers Revenue Share by Company (2021-2026) Table 7. Global Biomarkers Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomarkers Key Company Manufacturing Base & Headquarters Table 9. Global Biomarkers Company, Product Type & Application Table 10. Global Biomarkers Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sepsis Biomarkers Table 15. Significant Companies of Antibiotic Resistance Biomarkers Table 16. Significant Companies of Traumatic Brain Injury (TBI) Testing Biomarkers Table 17. Significant Companies of Stroke Testing Biomarkers Table 18. Significant Companies of Antibiotic Stewardship Biomarkers Table 19. Significant Companies of Other Table 20. Global Biomarkers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Biomarkers Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Biomarkers Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Biomarkers Sales Value Share by Type (2021-2026) Table 24. Global Biomarkers Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Diagnostics Table 26. Significant Companies of Drug Discovery Table 27. Significant Companies of Personalized Medicine Table 28. Significant Companies of Other Table 29. Global Biomarkers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biomarkers Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Biomarkers Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Biomarkers Sales Value Share by Application (2021-2026) Table 33. Global Biomarkers Sales Value Share by Application (2027-2032) Table 34. Global Biomarkers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biomarkers Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Biomarkers Sales Value Share by Region (2021-2026) Table 37. Global Biomarkers Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Biomarkers Sales Value Share by Region (2027-2032) Table 39. Global Biomarkers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Biomarkers Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Biomarkers Sales Value Market Share by Country (2021-2026) Table 42. Global Biomarkers Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Biomarkers Sales Value Market Share by Country (2027-2032) Table 44. Thermo Fisher Scientific Company Information Table 45. Thermo Fisher Scientific Business Overview Table 46. Thermo Fisher Scientific Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Thermo Fisher Scientific Biomarkers Product Portfolio Table 48. Thermo Fisher Scientific Recent Development Table 49. Merck Company Information Table 50. Merck Business Overview Table 51. Merck Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Merck Biomarkers Product Portfolio Table 53. Merck Recent Development Table 54. Bio-Rad Laboratories Company Information Table 55. Bio-Rad Laboratories Business Overview Table 56. Bio-Rad Laboratories Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Bio-Rad Laboratories Biomarkers Product Portfolio Table 58. Bio-Rad Laboratories Recent Development Table 59. QIAGEN Company Information Table 60. QIAGEN Business Overview Table 61. QIAGEN Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. QIAGEN Biomarkers Product Portfolio Table 63. QIAGEN Recent Development Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Roche Biomarkers Product Portfolio Table 68. Roche Recent Development Table 69. Danaher Corporation Company Information Table 70. Danaher Corporation Business Overview Table 71. Danaher Corporation Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Danaher Corporation Biomarkers Product Portfolio Table 73. Danaher Corporation Recent Development Table 74. Siemens Healthcare Company Information Table 75. Siemens Healthcare Business Overview Table 76. Siemens Healthcare Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Siemens Healthcare Biomarkers Product Portfolio Table 78. Siemens Healthcare Recent Development Table 79. Abbott Company Information Table 80. Abbott Business Overview Table 81. Abbott Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Abbott Biomarkers Product Portfolio Table 83. Abbott Recent Development Table 84. Agilent Technologies Company Information Table 85. Agilent Technologies Business Overview Table 86. Agilent Technologies Biomarkers Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Agilent Technologies Biomarkers Product Portfolio Table 88. Agilent Technologies Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Biomarkers Product Image Figure 2. Global Biomarkers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomarkers Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomarkers Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sepsis Biomarkers Image Figure 8. Antibiotic Resistance Biomarkers Image Figure 9. Traumatic Brain Injury (TBI) Testing Biomarkers Image Figure 10. Stroke Testing Biomarkers Image Figure 11. Antibiotic Stewardship Biomarkers Image Figure 12. Other Image Figure 13. Global Biomarkers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Biomarkers Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Biomarkers Sales Value Share by Type (2021-2032) Figure 16. Diagnostics Image Figure 17. Drug Discovery Image Figure 18. Personalized Medicine Image Figure 19. Other Image Figure 20. Global Biomarkers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biomarkers Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Biomarkers Sales Value Share by Application (2021-2032) Figure 23. Global Biomarkers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Biomarkers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Biomarkers Sales Value (2021-2032) & (US$ Million) Figure 26. North America Biomarkers Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Biomarkers Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Biomarkers Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Biomarkers Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Biomarkers Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Biomarkers Sales Value (2021-2032) & (US$ Million) Figure 32. South America Biomarkers Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Biomarkers Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Biomarkers Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Biomarkers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Biomarkers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Biomarkers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Sepsis Biomarkers
  • Antibiotic Resistance Biomarkers
  • Traumatic Brain Injury (TBI) Testing Biomarkers
  • Stroke Testing Biomarkers
  • Antibiotic Stewardship Biomarkers
  • Other
Applications
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche
  • Danaher Corporation
  • Siemens Healthcare
  • Abbott
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomarkers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomarkers Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomarkers Market Dynamics
  1. 2.1 Biomarkers Industry Trends
  2. 2.2 Biomarkers Industry Drivers
  3. 2.3 Biomarkers Industry Opportunities and Challenges
  4. 2.4 Biomarkers Industry Restraints
3 Biomarkers Market by Company
  1. 3.1 Global Biomarkers Company Revenue Ranking in 2025
  2. 3.2 Global Biomarkers Revenue by Company (2021-2026)
  3. 3.3 Global Biomarkers Company Ranking (2024-2026)
  4. 3.4 Global Biomarkers Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomarkers Company Product Type and Application
  6. 3.6 Global Biomarkers Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomarkers Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomarkers Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomarkers Market by Type
  1. 4.1 Biomarkers Type Introduction
  2. 4.1.1 Sepsis Biomarkers
  3. 4.1.2 Antibiotic Resistance Biomarkers
  4. 4.1.3 Traumatic Brain Injury (TBI) Testing Biomarkers
  5. 4.1.4 Stroke Testing Biomarkers
  6. 4.1.5 Antibiotic Stewardship Biomarkers
  7. 4.1.6 Other
  8. 4.2 Global Biomarkers Sales Value by Type
  9. 4.2.1 Global Biomarkers Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Biomarkers Sales Value by Type (2021-2032)
  11. 4.2.3 Global Biomarkers Sales Value Share by Type (2021-2032)
5 Biomarkers Market by Application
  1. 5.1 Biomarkers Application Introduction
  2. 5.1.1 Diagnostics
  3. 5.1.2 Drug Discovery
  4. 5.1.3 Personalized Medicine
  5. 5.1.4 Other
  6. 5.2 Global Biomarkers Sales Value by Application
  7. 5.2.1 Global Biomarkers Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Biomarkers Sales Value by Application (2021-2032)
  9. 5.2.3 Global Biomarkers Sales Value Share by Application (2021-2032)
6 Biomarkers Regional Value Analysis
  1. 6.1 Global Biomarkers Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomarkers Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomarkers Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomarkers Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomarkers Sales Value (2021-2032)
  7. 6.3.2 North America Biomarkers Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomarkers Sales Value (2021-2032)
  10. 6.4.2 Europe Biomarkers Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomarkers Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomarkers Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomarkers Sales Value (2021-2032)
  16. 6.6.2 South America Biomarkers Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomarkers Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomarkers Sales Value Share by Country, 2025 VS 2032
7 Biomarkers Country-level Value Analysis
  1. 7.1 Global Biomarkers Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomarkers Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomarkers Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomarkers Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomarkers Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomarkers Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomarkers Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomarkers Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomarkers Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomarkers Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomarkers Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomarkers Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomarkers Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomarkers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomarkers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomarkers Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomarkers Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomarkers Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomarkers Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomarkers Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomarkers Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomarkers Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomarkers Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomarkers Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomarkers Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomarkers Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomarkers Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomarkers Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomarkers Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomarkers Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomarkers Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomarkers Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomarkers Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomarkers Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomarkers Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomarkers Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomarkers Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomarkers Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomarkers Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomarkers Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomarkers Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomarkers Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomarkers Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomarkers Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomarkers Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomarkers Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomarkers Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomarkers Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomarkers Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomarkers Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomarkers Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomarkers Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomarkers Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomarkers Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomarkers Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomarkers Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomarkers Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomarkers Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomarkers Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomarkers Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomarkers Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomarkers Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomarkers Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomarkers Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomarkers Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomarkers Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomarkers Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomarkers Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomarkers Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomarkers Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomarkers Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomarkers Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomarkers Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomarkers Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomarkers Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomarkers Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomarkers Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomarkers Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomarkers Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomarkers Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomarkers Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomarkers Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomarkers Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomarkers Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomarkers Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomarkers Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomarkers Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomarkers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Biomarkers Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Biomarkers Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Biomarkers Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Bio-Rad Laboratories
  14. 8.3.1 Bio-Rad Laboratories Company Information
  15. 8.3.2 Bio-Rad Laboratories Business Overview
  16. 8.3.3 Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Rad Laboratories Biomarkers Product Portfolio
  18. 8.3.5 Bio-Rad Laboratories Recent Developments
  19. 8.4 QIAGEN
  20. 8.4.1 QIAGEN Company Information
  21. 8.4.2 QIAGEN Business Overview
  22. 8.4.3 QIAGEN Biomarkers Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QIAGEN Biomarkers Product Portfolio
  24. 8.4.5 QIAGEN Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Biomarkers Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Biomarkers Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Danaher Corporation
  32. 8.6.1 Danaher Corporation Company Information
  33. 8.6.2 Danaher Corporation Business Overview
  34. 8.6.3 Danaher Corporation Biomarkers Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Danaher Corporation Biomarkers Product Portfolio
  36. 8.6.5 Danaher Corporation Recent Developments
  37. 8.7 Siemens Healthcare
  38. 8.7.1 Siemens Healthcare Company Information
  39. 8.7.2 Siemens Healthcare Business Overview
  40. 8.7.3 Siemens Healthcare Biomarkers Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Siemens Healthcare Biomarkers Product Portfolio
  42. 8.7.5 Siemens Healthcare Recent Developments
  43. 8.8 Abbott
  44. 8.8.1 Abbott Company Information
  45. 8.8.2 Abbott Business Overview
  46. 8.8.3 Abbott Biomarkers Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abbott Biomarkers Product Portfolio
  48. 8.8.5 Abbott Recent Developments
  49. 8.9 Agilent Technologies
  50. 8.9.1 Agilent Technologies Company Information
  51. 8.9.2 Agilent Technologies Business Overview
  52. 8.9.3 Agilent Technologies Biomarkers Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Agilent Technologies Biomarkers Product Portfolio
  54. 8.9.5 Agilent Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst